Pessary Market Size & Share 2025 - 2034

Pessary Market Size

The global pessary market size was valued at USD 447.5 million in 2024 and is projected to exhibit 4.8% CAGR from 2025 to 2034. The increasing prevalence of pelvic organ prolapse and urinary incontinence, growing awareness of the importance of timely diagnosis and treatment, rising adoption of non-invasive treatment options, and expanding government support for women's health programs are driving revenue growth in the market.

The aging global population is increasing the demand for non-surgical treatments like pessaries, as older adults are more prone to developing pelvic floor disorders such as pelvic organ prolapse and urinary incontinence. A study published in September 2022 by the National Center for Biotechnology Information revealed that approximately 40% of women worldwide experience pelvic organ prolapse, a figure expected to rise as the population continues to age. Additionally, a sedentary lifestyle and obesity can weaken the pelvic floor, further increasing the risk of prolapse and urinary incontinence in women.
 

Pessaries, medical devices inserted into the vagina, provide structural support to pelvic organs. They are commonly used to treat conditions like pelvic organ prolapse and stress urinary incontinence. Available in a variety of shapes and sizes, pessaries can be tailored to meet individual patient needs and address specific medical conditions.
 

Pessary Market Trends

Several key trends, driven by technological advancements, patient preferences, and evolving healthcare delivery, are shaping the growth and development of the market:
 

• 3D-printed, patient-specific pessaries are transforming the market. Manufacturers now use advanced imaging, cloud software, and artificial intelligence to create pessaries that fit a woman’s unique anatomy. This improves comfort and effectiveness while addressing issues such as poor fit and discomfort often associated with standard designs.
   
• These innovations are driving demand for modern pessaries, with both patients and healthcare providers supporting them due to improved patient satisfaction and treatment outcomes.
   
• The adoption of telemedicine for pessary consultations is also on the rise. Telemedicine has made it easier for patients to access gynecological care, allowing virtual consultations for insertion, maintenance, and troubleshooting. This reduces the need for frequent clinic visits. Telemedicine is expected to continue growing as a practical option for both patients and healthcare providers, especially in rural and underserved areas.
   
• Elderly women, who face higher risks of pelvic floor disorders due to age-related muscle weakening and childbirth history, are increasingly opting for non-invasive pessaries. Pessaries offer a simple, effective solution for managing pelvic floor disorders without the need for invasive procedures, making them highly suitable for older adults.
   
• Additionally, governments and healthcare providers are placing greater emphasis on elderly care, further promoting the adoption of pessaries among the geriatric population.
   

Pessary Market Analysis

Based on type, the market is segmented into ring, donut, gellhorn and other types. Ring segment dominates the market with a share of 51.6% in 2024.
 

• The dominance of the ring segment is attributed to its broad applicability across a wide patient population. Ring pessaries are effective for treating mild to moderate prolapse and stress urinary incontinence, making them suitable for many patients.
   
• Additionally, ring pessaries are lightweight and flexible, offering comfort and reducing irritation, which allows for long-term use. This has led to their widespread adoption. According to the American Academy of Family Physicians, incontinence ring pessaries are among the most commonly used devices for treating stress urinary incontinence.
   

Based on application, the pessary market is segmented into mild pelvic organ prolapse, stress urinary incontinence, severe pelvic organ prolapse, and other applications. Mild pelvic organ prolapse segment dominates the market with a share of 42.9% in 2024.
 

• Pessaries are commonly recommended by medical practitioners as a first-line treatment for mild pelvic organ prolapse. Their non-invasive nature, ease of use, and ability to delay or eliminate the need for surgical interventions make them the preferred option for many patients.
   
• Furthermore, women with mild pelvic organ prolapse prefer pessary therapy due to its cost-effectiveness compared to surgical treatments. A May 2024 study published by the British Medical Journal found that pessary therapy is a more affordable option than surgery due to its lower costs.

Learn more about the key segments shaping this market

Download Free PDF

Based on end user, the pessary market is segmented into hospitals, ambulatory surgical centers, clinics, and other end users. The hospitals segment held a dominating share of 46.2% in the market in 2024.
 

• Hospitals are key facilities for diagnosing, treating, and managing pelvic floor disorders such as pelvic organ prolapse (POP) and stress urinary incontinence (SUI). Most pessary fittings, insertions, and follow-up procedures are conducted in hospitals.
   
• Additionally, hospitals offer both surgical and non-surgical pessary treatments, making them the go-to choice for a wide range of conditions, particularly for more severe cases of prolapse or stress urinary incontinence.

In 2024, the U.S. led the North American pessary market, generating a revenue of about USD 169.7 million.
 

• The high prevalence of pelvic disorders in the U.S. is driving the demand for pessaries as a non-invasive treatment option for women. According to the University of Chicago Medical Center, around 50% of women experience some form of prolapse, and more than 12% of American women may require surgery for it during their lifetime.
   
• Additionally, the increasing incidence of lifestyle-related disorders and obesity among women in the U.S. is further raising the risk of pelvic disorders. According to the Centers for Disease Control and Prevention, 42.1% of women aged 20 and above were obese in the U.S. by June 2021, driving the rising demand for pessary therapy.
   

The UK is set to see a robust expansion in its pessary market from 2025 to 2034.
 

• Growing awareness of non-invasive treatment options for pelvic disorders is fueling revenue growth in the UK’s market. Organizations such as the United Kingdom Continence Society (UKCS) are working to increase awareness of pessaries as a suitable treatment for pelvic disorders. In March 2021, UKCS announced the launch of UK Clinical Guidelines for best practices in the use of vaginal pessaries for pelvic organ prolapse.
   
• Furthermore, pessaries have become a common treatment for prolapse in NHS hospitals. According to a January 2024 study published by Manchester University, using pessaries could help the NHS save USD 715 per patient, lowering overall treatment costs for pelvic organ prolapse in the UK. As a result, the adoption of pessary therapy is growing, driving market expansion.
   

Japan's Pessary market is set for lucrative growth from 2025 to 2034.
 

• Japan has a highly developed healthcare system with advanced medical technology and skilled professionals, making it an ideal environment for the use of pessaries for pelvic disorders.
   
• The growing elderly population in Japan is contributing to an increase in pelvic disorder cases. According to the World Bank Group, approximately 30% of Japan's population was aged 65 or older in 2023. Older women are more prone to developing pelvic organ prolapse, driving the demand for minimally invasive treatments like pessaries.
   

Saudi Arabia's pessary market is expected to witness substantial growth during the forecast period.
 

• Saudi Arabia has invested heavily in its healthcare system, establishing advanced medical facilities, adopting modern technologies, and providing high-quality healthcare services. Public and private hospitals in the country offer specialized treatments like pessaries for pelvic disorders, positioning Saudi Arabia as a key market for these treatments in the Middle East and Africa.
   
• Pelvic disorders, including pelvic organ prolapse, are becoming more common in Saudi Arabia. This increase is attributed to factors such as higher obesity rates, reduced physical activity, and a growing elderly female population. A study published in January 2022 by the National Center for Biotechnology Information found that 60.2% of women in Riyadh, Saudi Arabia, had pelvic floor dysfunction. This high prevalence is driving strong demand for pessary therapy in the country.
   

Pessary Market Share

The market is fragmented, with a mix of domestic and international companies, both large and small. Key players such as CooperSurgical, Panpac Medical, Integra Lifesciences, and Dr. Arabin are focusing on strategies such as developing new products, forming partnerships, merging with other companies, and adopting new technologies to strengthen their market positions. As awareness about non-invasive treatments grows and the aging population increases, demand is rising. This is expected to drive stronger competition, with companies prioritizing innovation, improving distribution networks, and advancing technology to gain a larger market share.
 

Pessary Market Companies

Some of the eminent market participants operating in the pessary industry include:

• Artisan Medical
• Bioteque America
• Bliss GVS Pharma
• Bray Group (Ethos Partners)
• Coloplast Group
• Contiform International
• CooperSurgical
• Dr. Arabin
• Integra Lifesciences
• MedGyn Products
• Novomed group (Gyneas)
• Panpac Medical
• Personal Medical
• Smiths Group
• Sugar International
   

Pessary Industry News:

• In June 2024, Bray Group announced its acquisition by Ethos Partners. This strategic move signifies a pivotal moment in Bray Group's journey, promising sustained growth in the medical sector. With this acquisition, Bray Group is set to broaden its product range and venture into untapped markets.
   

The pessary market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Ring
• Donut
• Gellhorn
• Other types

Market, By Application

• Mild pelvic organ prolapse
• Stress urinary incontinence
• Severe pelvic organ prolapse
• Other applications

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Clinics
• Other end users

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Germany
  • UK
  • France
  • Spain
  • Italy
• Asia Pacific 
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America 
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa 
  • South Africa
  • Saudi Arabia
  • UAE